Navigating PUPSIT implementation challenges for high-viscosity oligonucleotide drug products
{{output}}
The implementation of the revised European Union (EU) EMA Annex 1 (effective August 2023) has introduced stricter requirements for the design and operation of sterile injectable manufacturing processes. Among these requirements, Pre-Use Post-Sterilization Inte... ...
